COMMUNIQUÉS West-GlobeNewswire

Bionet America, Inc. Launches New Brio XVet Multiparameter Veterinary Monitors
01/05/2024
Next-generation surgical monitors enhance safety and convenience for veterinary care TUSTIN, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Bionet America, Inc. today announced the launch of the new Brio XVet series, a [...]
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives
01/05/2024
Acquire cell therapy manufacturing facility with clinical and commercial capabilities Further ExacTcell platform for additional clinical trials based on successful completion of POC Highlight full year financial results [...]
electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024
01/05/2024
ROCKAWAY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the first [...]
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
01/05/2024
BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced leadership [...]
Goodness Growth Provides CREAM & Fire Updates
01/05/2024
– Josh Rosen to shed Interim title and become Chief Executive Officer; Company provides other key personnel updates – – Company receives a short-term extension of the maturity date on its credit facility – – Company [...]
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
01/05/2024
Prioritization of Peak’s ADC cancer therapeutic platform technology and Akari’s PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic disease Akari Therapeutics announces leadership changes in separate Akari [...]
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
01/05/2024
Busy is getting candid about navigating her ADHD diagnosis and treatment experience with Qelbree ® The percentage of women newly diagnosed with ADHD between 23-29 and 30-49 years of age nearly doubled in just two years [...]
Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases
01/05/2024
SAN DIEGO and RESEARCH TRIANGLE PARK, N.C. and SEATTLE, May 01, 2024 (GLOBE NEWSWIRE) -- Creyon Bio , Inc. ("Creyon"), a drug development company that engineers Oligonucleotide-Based Medicines (OBMs) with industry [...]
The Canadian Dermatology Association urges Canadians to protect themselves from skin cancer this summer
01/05/2024
OTTAWA, May 01, 2024 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA) has launched its annual month-long Sun Awareness Campaign. This year is focused on protecting children and adolescents; the campaign [...]
L’Association canadienne de dermatologie incite les Canadiens à se prémunir contre les cancers de la peau cet été
01/05/2024
OTTAWA, 01 mai 2024 (GLOBE NEWSWIRE) -- L’Association canadienne de dermatologie (ACD) lance sa campagne annuelle Prudence au soleil, d’une durée d’un mois. Cette année, l’accent sera mis sur la protection des enfants [...]
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8
01/05/2024
DUBLIN, Ireland, May 01, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a [...]
VYNE Therapeutics Announces Oral Presentations for VYN201 at the 2024 Society for Investigative Dermatology (SID) Annual Meeting
01/05/2024
Presentations will highlight positive preclinical and Phase 1b data of novel BET inhibitor, VYN201, in nonsegmental vitiligo BRIDGEWATER, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“ [...]
Auron Announces Oral Presentation on Preclinical Data from Proprietary AURIGIN™ Platform at the AI in Biomedicine Keystone Symposia
01/05/2024
NEWTON, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Auron Therapeutics , a biotechnology company focused on developing next-generation targeted therapies by identifying and inhibiting the oncogenic cell states of cancer, [...]
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024
01/05/2024
- CX-904 (masked EGFRxCD3 Probody ® T-cell engager) preliminary Phase 1a results to be presented from ongoing dose escalation study - - Management to hold conference call at 5 p.m. EDT / 2 p.m. PDT on May 8 th - SOUTH [...]
Pliant Therapeutics to Participate in Upcoming Investor Events
01/05/2024
SOUTH SAN FRANCISCO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the [...]
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
01/05/2024
BOTHELL, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces completion of enrollment of 78 subjects who were infected with influenza A in a randomized [...]
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
01/05/2024
WALTHAM, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]
Touro University Nevada College of Osteopathic Medicine Teaches Living Anatomy and Physiology with Vave Health Pocket Ultrasound
01/05/2024
Largest Medical School in Nevada Provides Every Student with Wireless, Portable Ultrasound SAN JOSE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Vave Health, the company on a mission to put ultrasound in every medical [...]
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
01/05/2024
Two-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases CAMBRIDGE, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT [...]

Pages